Company intelligence / Profile preview

Eurofins DiscoverX

Fremont, California, United Statesdiscoverx.com ↗

Ownership: Private
Development stage: Commercial

Overview

Eurofins DiscoverX does not develop its own therapeutics but provides validated cell-based assay products that have been used in the screening and validation of billions of data points for countless therapeutic programs globally. Their technologies are widely adopted by pharmaceutical companies for drug discovery research.

Therapeutic areas: OncologyMetabolic DisordersImmunology
Modalities: Small moleculeMonoclonal antibodyPeptidesRecombinant protein
Industry: Drug Discovery Services

Partnerships

Major pharmaceutical companies globally use their platforms; specific partnerships not listed publicly.

Beyond the preview

Go deeper on Eurofins DiscoverX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurofins DiscoverX.

Explore the full profile